T. Rowe Price Associates’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $361K | Sell |
|
|||||
|
2022
Q3 | $997K | Sell |
|
|||||
|
2022
Q2 | $986K | Sell |
|
|||||
|
2022
Q1 | $1.51M | Hold |
|
|||||
|
2021
Q4 | $1.11M | Hold |
|
|||||
|
2021
Q3 | $1.52M | Hold |
|
|||||
|
2021
Q2 | $1.59M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $3.62M | Sell |
|
|||||
|
2018
Q1 | $10.2M | Sell |
|
|||||
|
2017
Q4 | $13M | Buy |
|
|||||
|
2017
Q3 | $13.1M | Buy |
|
|||||
|
2017
Q2 | $4.36M | Buy |
|